Cargando…
Elevated Expression of RGS2 May Underlie Reduced Olfaction in COVID-19 Patients
Anosmia is common in COVID-19 patients, lasting for weeks or months following recovery. The biological mechanism underlying olfactory deficiency in COVID-19 does not involve direct damage to nasal olfactory neurons, which do not express the proteins required for SARS-CoV-2 infection. A recent study...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504192/ https://www.ncbi.nlm.nih.gov/pubmed/36143181 http://dx.doi.org/10.3390/jpm12091396 |